Plenary Lunch

October 27, 2010
12:00 p.m. - 1:30 p.m.

Sponsored by Centocor Ortho Biotech Inc.

Medical Innovation in the United States:  Will We Continue to Lead?

The United States has been at the forefront of medical innovation for decades; however,
given the expanding globalization of the industry, and uncertainties in the U.S. marketplace, many experts believe that we are at risk of losing our leadership position.

This panel will discuss opportunities and challenges for the United States in terms of
competitiveness in medical innovation, looking specifically at the opportunities for the
industry’s priorities in the next congressional session, the biggest threats facing the
industry, and the role of the states in supporting medical innovation.

Moderator:    

Don Bohn, vice president, U.S. government affairs, Johnson & Johnson
 
Panelists:

John Castellani, president and CEO, PhRMA
James Greenwood, president and CEO, BIO
Stephen Ubl, president and CEO, AdvaMed
 

Plenary Session

October 27, 2010
3:15 p.m. - 4:45 p.m.

Sponsored by Ernst & Young

An Overview of the Industry:  Past, Present, and Future

A discussion of the present and future state of the biotechnology industry nationally with insights into the Mid-Atlantic corridor will again be featured at this year's Symposium. Our speakers will also focus on some key trends that will provoke your thoughts and interest.  This back-by-popular demand panel will cover trends from the past, what is currently keeping CEOs and CFOs up at night, and what these experts see in the future.

Remarks by:

U.S. Senator Robert Menendez (D-NJ)

U.S. Representative Allyson Schwartz (D-PA)
13th District of Pennsylvania

Moderator:

Tony Torrington
Partner and New Jersey Life Science Leader
Ernst & Young

Panelists:

Doug Long
Vice President of Industry Relations
IMS Health

Stephen Simpson
Partner, Strategic Growth Markets
Ernst & Young